NexgenRx Inc.

NexgenRx Inc.

June 17, 2009 17:06 ET

NexgenRx Announces Issuance of Shares in Payment of Quarterly Debenture Interest

TORONTO, ONTARIO--(Marketwire - June 17, 2009) - NEXGENRX INC. ("NexgenRx" or the "Company") (TSX VENTURE:NXG) announces that it has issued 249,316 common shares, at a price of $0.16 per share, in lieu of cash payment of interest accrued on the $2,000,000 of convertible debentures issued in October 2007. The foregoing shares are subject to hold periods in accordance with applicable securities laws, which will expire on October 18, 2009. It is at the discretion of the Corporation to issue shares in lieu of cash as payment of interest on the convertible debentures.

About NexgenRx

NexgenRx is a growing health benefits management company engaged in the design, management and administration of health benefit plans offered by employers and other plan sponsors for the benefit of their employees and plan members. More information on NexgenRx can be found at

The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release.

Contact Information

  • NexgenRx Inc.
    Ronald C. Loucks
    President and CEO
    (416) 695-3393 x 801
    (647) 722-2920 (FAX)
    NexgenRx Inc.
    Jeff Dawley
    VP, Finance and CFO
    (416) 695-3393 x 806
    (647) 722-2921 (FAX)